HR 1060 · Modern Authentication of Pharmaceuticals Act of 2025
Referred to the House Committee on Energy and Commerce.
- Introduced
- Feb 6, 2025
- Latest action
- Feb 6, 2025
- Sponsor
- Rep. Donald G. Davis [D-NC-1]
- Policy area
- Health
- Cosponsors
- 3
Summary
Modern Authentication of Pharmaceuticals Act of 2025 This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable. The bill applies to products manufactured beginning five years after the bill's enactment.
Recent actions
- Feb 6, 2025 Referred to the House Committee on Energy and Commerce.
- Feb 6, 2025 Introduced in House
- Feb 6, 2025 Sponsor introductory remarks on measure. (CR H519)
- Feb 6, 2025 Introduced in House
Votes
No recorded votes are available for this bill.